bioRxivBiochemistry
Structural modeling and thermostability of a serine protease inhibitor belonging to the Kunitz family from the tick Rhipicephalus microplus
L. d. M. Bomediano-Camillo, G. C. Ferreira, A. F. A. Duran, F. R. S. da Silva, W. Garcia, A. L. Scott, S. D. Sasaki
Abstract
rBmTI-A is a recombinant serine protease inhibitor that belongs to the Kunitz-BPTI family and that was cloned from Rhipicephalus microplus tick. rBmTI-A has inhibitory activities on bovine trypsin, human plasma kallikrein, human neutrophil elastase and plasmin with dissociation constants in nM range. It is characterized by two inhibitory domains and each domain presents six cysteines that form three disulfide bonds, which contribute to the high stability of its structure. Previous studies suggest that serine protease inhibitor rBmTI-A has a protective potential against pulmonary emphysema in mice and anti-inflammatory potential, besides rBmTI-A presented a potent inhibitory activity against in vitro vessel formation. In this study, the tertiary structure of BmTI-A was modeled based on the structure of its Sabellastarte magnifica homologue. The structure stabilization was evaluated by molecular dynamics analysis. Circular dichroism data corroborated the secondary structure found by the homology modeling. Thermostability analysis confirmed the thermostability and the relation between the effects of the temperature in the inhibitor activity. The loss of activity observed was gradual, and, after 60 minutes of incubation at 90{degrees}C the inhibitor lost it completely.
- assay: protein structure
- research focus: protein structure prediction
- approach: deep learning
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- KLK4 inhibition by cyclic and acyclic peptides: structural and dynamical insights into standard-mechanism protease inhibitors
B. T. Riley, O. Ilyichova, … A. Buckle·bioRxiv·Mar 8, 2019
- A novel inhibitor of complement C5 provides structural insights into activation
M. Reichhardt, S. Johnson, … S. M. Lea·bioRxiv·Jun 10, 2019
- Functional Implications Of Disordered Terminal Regions Of Macrotyloma uniflorum Bowman-Birk Inhibitors: A Molecular Dynamics Study
Abhishek Acharya·bioRxiv·Apr 9, 2017
- Cryo-EM structure of the transcription termination factor Rho from Mycobacterium tuberculosis reveals mechanism of resistance to bicyclomycin
Emmanuel Saridakis, Rishi Kishore Vishwakarma, … Marc Boudvillain·Communications BiologyPeer-reviewed·Feb 9, 2022
- Borrelia burgdorferi infection-enhanced Ixodes scapularis serpins S12c5 and S13c5, target MASP1/3 to inhibit MBL-pathway complement activation and promote spirochete survival
Emily Bencosme-Cuevas, Tae Kim, … Albert Mulenga·bioRxiv·Jun 26, 2026
- Pre-bound State Discovered in the Unbinding Pathway of Fluorinated Variants of the Trypsin-BPTI Complex Using Random AccelerationMolecular Dynamics Simulations
L. Wehrhan, B. G. Keller·bioRxiv·Feb 22, 2024